The global laboratory centrifuges market is projected to grow from USD 1.58 billion in 2025 to USD 1.86 billion by 2030, registering a CAGR of 2.8% during the forecast period. Laboratory centrifuges remain indispensable tools across scientific research, clinical diagnostics, biotechnology, and pharmaceutical applications, where they play a critical role in separating and purifying biological and chemical components.
As laboratories continue to expand research capabilities and increase testing volumes, demand for advanced centrifugation technologies is steadily rising. Centrifuges are extensively used for isolating cells, proteins, nucleic acids, viruses, and subcellular organelles, making them fundamental to modern life science workflows.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088
Key Factors Driving Market Growth
Several factors are contributing to the growth of the laboratory centrifuges market. One of the most significant drivers is the increasing investment in research and development by pharmaceutical, biotechnology, and academic institutions worldwide. Governments and private organizations are also providing substantial research grants to accelerate innovation in healthcare and life sciences.
Another important growth factor is the rising prevalence of infectious diseases, which has increased the demand for laboratory testing, molecular diagnostics, and cell-based research. The need for rapid and accurate sample preparation has further strengthened the role of centrifuges in laboratory operations.
Technological advancements are also transforming the market landscape. Manufacturers are introducing innovative rotor designs, enhanced safety features, improved energy efficiency, and automated functionalities that increase productivity while reducing operational complexity. These innovations are helping laboratories optimize workflows and achieve more reliable research outcomes.
Additionally, expanding applications in genomics, proteomics, cell therapy research, and personalized medicine continue to create new opportunities for laboratory centrifuge manufacturers.
Asia Pacific Emerges as the Fastest-Growing Region
The Asia Pacific region is expected to witness the highest growth during the forecast period. Emerging economies such as China and India are investing heavily in healthcare infrastructure, biotechnology research, and pharmaceutical manufacturing. Growing government support for scientific research, coupled with increasing private-sector investments, is creating favorable conditions for market expansion.
The region’s expanding clinical research activities and rising demand for advanced laboratory equipment are expected to make Asia Pacific a key growth engine for the global laboratory centrifuges market over the next decade.
Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=197749088
Leading Companies Shaping the Competitive Landscape
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher Scientific is widely regarded as the market leader in laboratory centrifuges. The company’s success is driven by its extensive product portfolio, strong global distribution network, and significant investments in research and development. By consistently introducing innovative products and participating in major scientific conferences, workshops, and industry events, Thermo Fisher continues to strengthen its market position.
With operations spanning more than 600 locations worldwide, the company maintains a strong presence across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Danaher Corporation (US)
Danaher has established itself as a major competitor through strategic acquisitions and continuous product innovation. The acquisition of Beckman Coulter significantly expanded Danaher’s clinical diagnostics and laboratory equipment portfolio, enhancing its competitive position in the centrifuges market.
The company’s commitment to innovation is reflected in products such as the Avanti JXN-30 centrifuge. Through the Danaher Business System (DBS), the organization continues to improve operational excellence and integrate acquired businesses efficiently across its global network.
Eppendorf AG (Germany)
Eppendorf is recognized for its strong focus on product development and customer-centric innovation. The company has introduced several advanced centrifuge models, including the Multipurpose Centrifuge 5910 Ri and the Refrigerated Centrifuge 5425 series, helping expand its market presence.
The acquisition of Koki Holdings Co., Ltd.’s centrifuge business further strengthened Eppendorf’s portfolio, enabling the company to offer a broader range of high-speed and ultra-speed centrifuges. With subsidiaries in more than 28 countries, Eppendorf maintains a strong international footprint.
Market Ranking and Outlook
The laboratory centrifuges market remains fairly consolidated, with approximately 50–60% of global market share controlled by a handful of major players. Thermo Fisher Scientific leads the industry, followed by Danaher Corporation and Eppendorf AG. These companies continue to strengthen their positions through technological innovation, strategic acquisitions, workflow integration, and global expansion initiatives.
As life science research, molecular diagnostics, and biopharmaceutical development continue to grow worldwide, laboratory centrifuges will remain essential instruments supporting scientific discovery and healthcare advancements, ensuring steady market growth through 2030.
For more information, Inquire Now!
